Emulation Differences vs. Biases When Calibrating Real-World Evidence Findings Against Randomized Controlled Trials

被引:35
|
作者
Franklin, Jessica M. [1 ]
Glynn, Robert J. [1 ]
Suissa, Samy [2 ,3 ,4 ]
Schneeweiss, Sebastian [1 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
[2] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada
[3] McGill Univ, Dept Biostat, Montreal, PQ, Canada
[4] McGill Univ, Dept Occupat Hlth, Montreal, PQ, Canada
关键词
D O I
10.1002/cpt.1793
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Actionable real-world evidence (RWE) requires accurate estimation of causal treatment effects. Calibration of RWE against randomized controlled trials (RCTs) is sometimes done to demonstrate that RWE can support the same causal conclusion as RCTs. Disagreements can occur when studies in each pair asked different questions in different populations or due to the presence of residual bias. Distinguishing among reasons for differences will impact the level of confidence in RWE.
引用
收藏
页码:735 / 737
页数:3
相关论文
共 50 条
  • [21] Plug-stat® : a cloud-based application to facilitate the emulation of clinical trials for real-world evidence based on real-world data
    Foucher, Yohann
    Loncle, Cyrille
    Le Borgne, Florent
    HEALTH SERVICES AND OUTCOMES RESEARCH METHODOLOGY, 2023, 23 (03) : 266 - 279
  • [22] From Randomized Controlled Trials to the Real World: Putting Evidence into Context
    Blonde, Lawrence
    Dendy, Jared A.
    Skolnik, Neil
    White, John R., Jr.
    JOURNAL OF FAMILY PRACTICE, 2018, 67 (08): : S55 - S60
  • [23] Ideal vs. real: a systematic review on handling covariates in randomized controlled trials
    Ciolino, Jody D.
    Palac, Hannah L.
    Yang, Amy
    Vaca, Mireya
    Belli, Hayley M.
    BMC MEDICAL RESEARCH METHODOLOGY, 2019, 19 (1)
  • [24] Ideal vs. real: a systematic review on handling covariates in randomized controlled trials
    Jody D. Ciolino
    Hannah L. Palac
    Amy Yang
    Mireya Vaca
    Hayley M. Belli
    BMC Medical Research Methodology, 19
  • [25] Synergies From Integrating Randomized Controlled Trials and Real-World Data Analyses
    Najafzadeh, Mehdi
    Gagne, Joshua J.
    Schneeweiss, Sebastian
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (06) : 914 - 916
  • [26] ARE REAL-WORLD PROSTATE CANCER PATIENTS ADEQUATELY REPRESENTED IN RANDOMIZED CONTROLLED TRIALS
    Ganem, P. K.
    Henegan, J. C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 675 - 675
  • [27] A meta-analysis of effectiveness of real-world studies of antipsychotics in schizophrenia: Are the results consistent with the findings of randomized controlled trials?
    Katona, Lajos
    Bitter, Istvan
    Czobor, Pal
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [28] A meta-analysis of effectiveness of real-world studies of antipsychotics in schizophrenia: Are the results consistent with the findings of randomized controlled trials?
    Lajos Katona
    István Bitter
    Pál Czobor
    Translational Psychiatry, 11
  • [29] Randomised-controlled trials and real-world evidence for optimising TB management
    Taylor, J. W.
    Denholm, J. T.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2022, 26 (05) : 383 - 384
  • [30] Differences in safety profiles of newly approved medications for multiple myeloma in real-world settings versus randomized controlled trials
    Borrelli, Eric P.
    McGladrigan, Conor G.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (04) : 887 - 896